TipRanks
Tvardi Therapeutics (CH:TVRD)
:TVRD
Switzerland Market
TVRD
Tvardi Therapeutics
RESEARCH TOOLSreports

Tvardi Therapeutics (TVRD) Stock News & Sentiment

2 Followers
Tvardi Maintained at Buy as Analyst Highlights Differentiated STAT3 Approach in UC; Price Target Reaffirmed at $9
Premium
Ratings
Tvardi Maintained at Buy as Analyst Highlights Differentiated STAT3 Approach in UC; Price Target Reaffirmed at $9
2M ago
TVRD
Analyst Maintains Buy on Tvardi Therapeutics, Lowers Price Target to $5 on Updated Assumptions and Funding Needs
Premium
Ratings
Analyst Maintains Buy on Tvardi Therapeutics, Lowers Price Target to $5 on Updated Assumptions and Funding Needs
2M ago
TVRD
Tvardi: Strategic Pivot to Ulcerative Colitis and Upcoming HCC Readouts Support Unchanged $9 Price Target and Buy Rating
Premium
Ratings
Tvardi: Strategic Pivot to Ulcerative Colitis and Upcoming HCC Readouts Support Unchanged $9 Price Target and Buy Rating
2M ago
TVRD
Tvardi Therapeutics Targets Ulcerative Colitis With STAT3 Inhibitor
Premium
Company Announcements
Tvardi Therapeutics Targets Ulcerative Colitis With STAT3 Inhibitor
3M ago
8K
TVRD
Tvardi Therapeutics Expands At-The-Market Equity Program
Premium
Company Announcements
Tvardi Therapeutics Expands At-The-Market Equity Program
3M ago
8K
TVRD
Snap, AT&T, Lemonade, Tvardi, Dollar Tree Trending by Analysts
Premium
Weekend Updates
Snap, AT&T, Lemonade, Tvardi, Dollar Tree Trending by Analysts
3M ago
T
DLTR
Why Is Penny Stock Tvardi Therapeutics (TVRD) Up Today?
Premium
Market News
Why Is Penny Stock Tvardi Therapeutics (TVRD) Up Today?
3M ago
TVRD
More CH:TVRD News >

TVRD News on the Web

Tvardi Therapeutics (TVRD) Gets a Sell from Barclays
TipRanks News
Neutral
Tvardi: Strategic Pivot to Ulcerative Colitis and Upcoming HCC Readouts Support Unchanged $9 Price Target and Buy Rating
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Spyre Therapeutics (SYRE), Stereotaxis (STXS) and Tvardi Therapeutics (TVRD)
TipRanks News
Bullish
Tvardi Therapeutics Expands At-The-Market Equity Program
TipRanks News
Neutral
Snap, AT&T, Lemonade, Tvardi, Dollar Tree Trending by Analysts
TipRanks News
Bullish
Tvardi Therapeutics upgraded to Overweight at Piper after Phase 1 data
TipRanks News
Bullish
Tvardi Therapeutics upgraded to Overweight from Neutral at Piper Sandler
TipRanks News
Bullish
Why Is Penny Stock Tvardi Therapeutics (TVRD) Up Today?
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0.75 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

FAQ

What is CH:TVRD’s Media Buzz Sentiment?
Currently, no data Available
What is CH:TVRD’s weekly average amount of articles?
In an average week, 0.75 articles about CH:TVRD are published.
    What is CH:TVRD’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    IQVIQVIA Holdings
    GILDGilead Sciences
    ABBVAbbVie
    VRTXVertex Pharmaceuticals
    NVSNovartis
    Showing the stocks with the most bullish news sentiment over the past week